ADARB2 and neoplasm: The highest mutation frequency was presented in CPSF1, followed by ADARB2 and KIAA1429 (Figure 1A), while METTL3, METTL14, TRMT61A, TRMT61B, CSTF3, and NUDT2 did not show any mutations in tumor samples.